The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determining the prevalence of germline BAP1 mutations in malignant mesothelioma (MM).
 
Marjorie Glass Zauderer
Consulting or Advisory Role - AstraZeneca/MedImmune
Research Funding - Epizyme (Inst); MedImmune (Inst); Polaris (Inst); Sellas Life Sciences (Inst); Verastem (Inst)
 
Mariel A. DuBoff
No Relationships to Disclose
 
Beth Siegel
No Relationships to Disclose
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; McKesson
Research Funding - AbbVie (Inst); AstraZeneca (Inst); Biomarin (Inst); Medivation (Inst); Myriad Genetics (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Angela G. Arnold
No Relationships to Disclose
 
Janice Berliner
No Relationships to Disclose
 
Megan Harlan Fleischut
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Marc Ladanyi
Honoraria - Merck (I)
Consulting or Advisory Role - NCCN/AstraZeneca; NCCN/Boehringer Ingelheim
Research Funding - Loxo (Inst)